Bio-Techne
TECH
$64.06
Share price
2.23%
Change (1 day)
-19.80%
Change (1 year)
Categories
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
Market capitalization of Bio-Techne (TECH)
Market cap: $10.06 Billion
As of April 2024 Bio-Techne has a market cap of $10.06 Billion. This makes Bio-Techne the world's 1600th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Bio-Techne from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $10.06 B | -17.48% |
| 2023 | $12.20 B | -6.2% |
| 2022 | $13.00 B | -36% |
| 2021 | $20.32 B | 65.81% |
| 2020 | $12.26 B | 45.9% |
| 2019 | $8.40 B | 53.88% |
| 2018 | $5.46 B | 12.52% |
| 2017 | $4.85 B | 26.5% |
| 2016 | $3.83 B | 14.62% |
| 2015 | $3.34 B | -2.38% |
| 2014 | $3.42 B | -1.84% |
| 2013 | $3.49 B | 38.75% |
| 2012 | $2.51 B | -0.31% |
| 2011 | $2.52 B | 3.61% |
| 2010 | $2.43 B | -4.58% |
| 2009 | $2.55 B | 5.61% |
| 2008 | $2.41 B | -6.6% |
| 2007 | $2.58 B | 18.56% |
| 2006 | $2.18 B | 0.17% |
| 2005 | $2.18 B | 35.67% |
| 2004 | $1.60 B | 3.5% |
| 2003 | $1.55 B | 30.89% |
| 2002 | $1.18 B | -22.43% |
| 2001 | $1.52 B |
End of Day market cap according to different sources
On Apr 28th, 2024 the market cap of Bio-Techne was reported to be:
$10.06 Billion
$10.06 Billion
$10.06 Billion
$10.06 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $218.95 B | 2,074.35% | 🇺🇸 USA |
 Becton Dickinson BDX | $66.89 B | 564.32% | 🇺🇸 USA |
 General Electric GE | $177.70 B | 1,664.80% | 🇺🇸 USA |
 Danaher DHR | $182.63 B | 1,713.74% | 🇺🇸 USA |
 Qiagen QGEN | $9.21 B | -8.44% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | $53.78 M | -99.47% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $7.88 B | -21.65% | 🇺🇸 USA |